Skip to main content

Persistent Asset Partners Ltd

Position in EWTX — Edgewise Therapeutics, Inc.

CIK 2056052 HONG KONG, K3

Position in EWTX

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$2,821,387
+$2,504,718 QoQ
Shares Held
69,441
+590.7% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#83
of 223 holders
Holding Since
Dec 2024
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EWTX Over Time

Shares Held

Position Value (USD)

Derivatives in EWTX

reported options exposure · as of Mar 31, 2026
CallValue
$16,978
CallShares
539
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Persistent Asset Partners Ltd holds $74,585,923 across 142 Biotechnology names. EWTX ranks #6 (3.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 EWTX
Edgewise Therapeutics, Inc.
This page
69,441 $2,821,387

All Filings in EWTX

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,821,387 69,441
2026-03-31 $316,669 10,053
2026-03-31 $16,978 539
2025-12-31 $526,177 21,204
2024-12-31 $2,670 100
2024-12-31 $443,033 16,593